Buprenorphine Hydrochloride
11 NDCs across 3 manufacturers|4 Generic,7 Brand
Buprenorphine Hydrochloride is used to treat heroin dependence and pain, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jun 3, 1996. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient.
Buprenorphine Hydrochloride is available as 11 NDCs from 3 manufacturers (4 generic, 7 brand), with NADAC prices from $0.28 to $18.59 per EA — the most expensive product costs about 67× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
4G / 7B
Manufacturers
3
competing in market
Price Spread
$0.28 – $18.59
per EA
7d Activity
avg +0.9% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
BioDelivery Sciences International Inc manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Partial Opioid Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing BUPRENORPHINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BELBUCA 900 MCG FILM | $18.5906 per EA | -0.03% |
BELBUCA 750 MCG FILM | $18.0990 per EA | +0.02% |
BELBUCA 600 MCG FILM | $17.1903 per EA | -0.08% |
BELBUCA 450 MCG FILM | $16.1142 per EA | -0.09% |
BELBUCA 300 MCG FILM | $11.8563 per EA | +0.06% |
BELBUCA 150 MCG FILM | $7.5576 per EA | +0.05% |
BELBUCA 75 MCG FILM | $7.5417 per EA | +0.02% |
BUPRENORPHINE 8 MG TABLET SL | $0.5714 per EA | +0.67% |
BUPRENORPHINE 8 MG TABLET SL | $0.5714 per EA | +0.67% |
BUPRENORPHINE 2 MG TABLET SL | $0.2768 per EA | +4.53% |
BUPRENORPHINE 2 MG TABLET SL | $0.2768 per EA | +4.53% |
Frequently Asked Questions
What is Buprenorphine Hydrochloride used to treat?
Buprenorphine Hydrochloride is used to treat heroin dependence and pain, per the National Library of Medicine's MED-RT classification.
When did Buprenorphine Hydrochloride become available as a generic?
FDA approved the first generic Buprenorphine Hydrochloride (ANDA) on Jun 3, 1996. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Buprenorphine Hydrochloride products are on the market?
The Buprenorphine Hydrochloride drug market contains 11 NDCs from 3 manufacturers — 4 generic and 7 brand products.
What is the price range for Buprenorphine Hydrochloride?
NADAC reference prices for Buprenorphine Hydrochloride range from $0.2768 to $18.5906 per EA — the most expensive product costs about 67× the cheapest.
Is generic Buprenorphine Hydrochloride cheaper than brand?
The average generic NADAC for Buprenorphine Hydrochloride is $0.4241 per EA, versus $13.8500 for brand-labeled products — brand versions average about 33× the generic price.
Which manufacturers make Buprenorphine Hydrochloride?
3 manufacturers list Buprenorphine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are BioDelivery Sciences International Inc (7), Advagen Pharma Ltd. (2), PAI Holdings LLC (2).
How has the price of Buprenorphine Hydrochloride changed recently?
Over the past 7 days, 8 Buprenorphine Hydrochloride NDCs rose and 3 fell, with a market-wide average change of +0.9%.